Abstracts tagged "familial Mediterranean fever and outcome measures"

Abstract Number: 1484 • 2015 ACR/ARHP Annual Meeting
Development and Validation of Juvenile Autoinflammatory Disease Multidimensional Assessment Report (JAIMAR)
Dilek Konukbay¹, Dilek Yildiz¹, Cengizhan Acikel^2,3, betul sozeri⁴, Balahan Makay⁵, Nuray Aktay Ayaz Sr.⁶, Kenan Barut⁷, Aysenur Kisaarslan⁸, Yelda Bilginer⁹, Harun Peru¹⁰, Ozlem Aydog¹¹, Erbil Unsal¹², Ozgur Kasapcopur¹³, Zubeyde Gunduz⁸, Seza Ozen¹⁴ and Erkan Demirkaya¹⁵, ¹Gulhane Military Medical Faculty, Ankara, Turkey, ²Biostatistics, Gulhane Military Medical Faculty, Ankara, Turkey, ³Department of Bioistatistics, Gulhane Military Medical Academy, Ankara, Turkey, ⁴Pediatric Rheumatology, Ege University Faculty of Medicine, Izmir, Turkey, ⁵Pediatric Rheumatology, Eylul University, Izmir, Turkey, ⁶Pediatric Rheumatology, Istanbul KSS Education and Research Hospital, Istanbul, Turkey, ⁷Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University., Fellow in Pediatric Rheumatology, Istanbul, Turkey, ⁸Pediatric Rheumatology, Erciyes University Faculty of Medicine, Kayseri, Turkey, ⁹Department of Pediatric Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, ¹⁰Pediatric Rheumatology, Selcuklu Medical Faculty, Konya, Turkey, ¹¹Pediatric Rheumatology, Dr. Sami Ulus Children's Hospital, Ankara, Turkey, ¹²Pediatric Rheumatology, 9 Eylul University Faculty of Medicine, Izmir, Turkey, ¹³Pediatric Rheumatology, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey, ¹⁴Deptartment. of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey, ¹⁵Pediatric Rheumatology, Gulhane Military Medical Academy, FMF Arthritis Vasculitis and Orphan disease Research Center (FAVOR),, Ankara, Turkey
Background/Purpose: There are lots of effects of auto-inflammatory diseases (e.g. pain, fatigue, fear of attack, lifelong drug use, being nervous and angry, problems at school)…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].